SOX2 and central nervous system cancer: Some transcriptional factors with well-recognized functions in embryonic development, such as Nanog, Oct4, Sox2, STAT3, have been identified as oncogenic drivers which can affect the fate of glioma stem cells and regulation of glioma development (32).